RheoGene Receives $2M NIST Grant | GenomeWeb

NEW YORK, Oct. 19 – The National Institute of Standards and Technology’s Advanced Technology Program has awarded RheoGene of Charlottesville, Va., a three-year, $2 million grant for gene-targeting technology, the company said.

RheoGene said it would use the funding to improve its gene-targeting technology, which is designed to allow researchers to insert and delete gene sequences in nuclear and mitochondrial genomes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."